Smith Group Asset Management’s Anika Therapeutics ANIK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-1,360
| Closed | -$41K | – | 407 |
|
|
2019
Q1 | $41K | Sell |
1,360
-80
| -6% | -$2.41K | ﹤0.01% | 311 |
|
|
2018
Q4 | $48K | Hold |
1,440
| – | – | ﹤0.01% | 302 |
|
|
2018
Q3 | $61K | Hold |
1,440
| – | – | ﹤0.01% | 292 |
|
|
2018
Q2 | $46K | Hold |
1,440
| – | – | ﹤0.01% | 337 |
|
|
2018
Q1 | $72K | Sell |
1,440
-50
| -3% | -$2.5K | ﹤0.01% | 316 |
|
|
2017
Q4 | $80K | Hold |
1,490
| – | – | ﹤0.01% | 296 |
|
|
2017
Q3 | $86K | Sell |
1,490
-1,410
| -49% | -$81.4K | ﹤0.01% | 295 |
|
|
2017
Q2 | $143K | Sell |
2,900
-1,330
| -31% | -$65.6K | ﹤0.01% | 281 |
|
|
2017
Q1 | $184K | Sell |
4,230
-2,030
| -32% | -$88.3K | 0.01% | 278 |
|
|
2016
Q4 | $306K | Sell |
6,260
-200
| -3% | -$9.78K | 0.01% | 220 |
|
|
2016
Q3 | $309K | Buy |
6,460
+130
| +2% | +$6.22K | 0.01% | 216 |
|
|
2016
Q2 | $340K | Sell |
6,330
-65,070
| -91% | -$3.5M | 0.01% | 210 |
|
|
2016
Q1 | $3.19M | Buy |
71,400
+250
| +0.4% | +$11.2K | 0.1% | 105 |
|
|
2015
Q4 | $2.72M | Buy |
71,150
+69,440
| +4,061% | +$2.65M | 0.08% | 118 |
|
|
2015
Q3 | $54K | Sell |
1,710
-113
| -6% | -$3.57K | ﹤0.01% | 283 |
|
|
2015
Q2 | $59K | Sell |
1,823
-91,184
| -98% | -$2.95M | ﹤0.01% | 276 |
|
|
2015
Q1 | $3.83M | Sell |
93,007
-5,120
| -5% | -$211K | 0.13% | 113 |
|
|
2014
Q4 | $4M | Sell |
98,127
-2,840
| -3% | -$116K | 0.14% | 118 |
|
|
2014
Q3 | $3.7M | Buy |
100,967
+653
| +0.7% | +$23.9K | 0.14% | 122 |
|
|
2014
Q2 | $4.65M | Sell |
100,314
-15,909
| -14% | -$737K | 0.17% | 104 |
|
|
2014
Q1 | $4.78M | Sell |
116,223
-16,169
| -12% | -$665K | 0.18% | 100 |
|
|
2013
Q4 | $5.05M | Sell |
132,392
-18,499
| -12% | -$706K | 0.19% | 96 |
|
|
2013
Q3 | $3.61M | Sell |
150,891
-15,582
| -9% | -$372K | 0.15% | 116 |
|
|
2013
Q2 | $2.83M | Buy |
+166,473
| New | +$2.83M | 0.12% | 142 |
|